Ngā hua rapu - Guo, Renyong
- E whakaatu ana i te 1 - 14 hua o te 14
-
1
-
2
-
3
-
4
-
5
-
6
-
7
Increased von Willebrand factor over decreased ADAMTS‐13 activity is associated with poor prognosis in patients with advanced non‐small‐cell lung cancer mā Guo, Renyong, Yang, Jiezuan, Liu, Xia, Wu, Jianping, Chen, Yu
I whakaputaina 2017Text -
8
-
9
-
10
-
11
Slow reduction of IP-10 Levels predicts HBeAg seroconversion in chronic hepatitis B patients with 5 years of entecavir treatment mā Guo, Renyong, Mao, Hejun, Hu, Xiao, Zheng, Nengneng, Yan, Dong, He, Jianqin, Yang, Jiezuan
I whakaputaina 2016Text -
12
Increasing plasma ADAMTS13 activity is associated with HBeAg seroconversion in chronic hepatitis B patients during 5 years of entecavir treatment mā Guo, Renyong, Xie, Yirui, Yang, Jiezuan, Lu, Haifeng, Ye, Ping, Jin, Linfeng, Lin, Wenqin
I whakaputaina 2019Text -
13
Plasma Level of ADAMTS13 or IL-12 as an Indicator of HBeAg Seroconversion in Chronic Hepatitis B Patients Undergoing m-ETV Treatment mā Yang, Jiezuan, Guo, Renyong, Yan, Dong, Lu, Haifeng, Zhang, Hua, Ye, Ping, Jin, Linfeng, Diao, Hongyan, Li, Lanjuan
I whakaputaina 2020Text -
14
Predictive value of serum ALT and T-cell receptor beta variable chain for HBeAg seroconversion in chronic hepatitis B patients during tenofovir treatment mā Yang, Jiezuan, Yan, Dong, Guo, Renyong, Chen, Jiajia, Li, Yongtao, Fan, Jun, Fu, Xuyan, Yao, Xinsheng, Diao, Hongyan, Li, Lanjuan
I whakaputaina 2017Text